Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: john.d who wrote (10610)	8/18/2002 10:02:22 PM
From: john.d	Read Replies (1) \| Respond to of 14101

One other thing does anyone know who I can shrink the chart so that i can print on only one page. I tried but was unsuccessful. Thanks John

To: john.d who wrote (10610)	8/18/2002 10:11:29 PM
From: Joe Krupa	Read Replies (1) \| Respond to of 14101

Thanks John, Wolf, Ron, Jim and Cal. I've had that chart in my mind for a long time, but wanted to share it with all. I have felt the pieces of the FDA puzzle coming together ever since Rebecca's "great comfort and great confidence" comment last August. I also notice that the head to head trials, underway right now, against the Cox-2s and oral diclofenac, seemed to be initiated right around the time Dimethaid was likely starting labeling talks with the FDA. I have little doubt these are marketing trials for favourable labeling claims. In fact, given these trials were 12 weeks in duration, and started back in April (or earlier), they could likely be concluded already. Is anyone else having trouble getting into the S$%thouse Bullboards tonight? joe